source Post navigation Cardiorenal protection with dapagliflozin in patients with type 2 diabetes mellitus and chronic coronary syndrome undergoing percutaneous coronary intervention: a registry cross-sectional study – BioMed Central Eastern Shore Rural Health free Diabetes Prevention Program begins April 29 – Shore Daily News